Release Date: 29/04/22 09:39 Summary: Quarterly Company Update Price Sensitive: Yes Download Document 241.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%